Clinical Trial Update: Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety, preliminary efficacy, and pharmacokinetics of CT-707 in patients with ALK-positive non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CT-707 (CT-707)

Snippet

Sponsor: Centaurus Biopharma Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: UNKNOWN